Comprehensive search ChatGPT Online Scientific research tools
Sign in Sign Up

Science hub Mutual Aid community


[Other] Tenecteplase versus alteplase for the management of acute ischaemic stroke in Norway (NOR-TEST 2, part A): a phase 3, randomised, open-label, blinded endpoint, non-inferiority trial

thoai Post time 2024-4-27 11:07:32 | Show all posts |Read mode
Reward40points

Edited by thoai at 2024-4-27 11:32

Tenecteplase versus alteplase for the management of acute ischaemic stroke in Norway (NOR-TEST 2, part A): a phase 3, randomised, open-label, blinded endpoint, non-inferiority trial

Best Answer

spleen Junior Member
2024-4-27
Please adopt

View Full Content

You can support us by donating, we would be very grateful.
Reply

Use magic Donate Report

All Reply1 Show all posts
spleen Post time 2024-4-27 11:07:33 | Show all posts

This post has been completed

Completed attachments will be deleted within 24 hours.
You can support us by donating, we would be very grateful.
Reply

Use magic Donate Report


thoai Lv.2
Junior Member

  • post

  • reply

  • points

    20

Same Category

Latest Reply

Announcement

Enthusiastic users today